Tenderwize
Retour à la recherche

Package 1 Onasemnogenum abeparvovecum

GÓRNOŚLĄSKIE CENTRUM ZDROWIA DZIECKA im. św. JANA PAWŁA II Samodzielny Publiczny Szpital Kliniczny Nr 6 Śląskiego Uniwersytetu Medycznego w Katowicach·Katowice, Poland·Expired · Aug 17, 2026·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Poland – Pharmaceutical products – Dostawy leku Onasemnogenum abeparvovecum stosowanego w programie lekowym B.102.FM dla Górnośląskie Centrum Zdrowia Dziecka im. św. Jana Pawła II Samodzielny Publiczny Szpital Kliniczny nr 6 Śląskiego Uniwersytetu Medycznego w Katowicach 40-752 Katowice ul. Medyków 16

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

30 / 100

Facteurs de risque

No estimated value or detailed scope of work provided; key documents (attachment 2) not analyzed.

Structured data indicates EU funding (isEuFunded: true), but XML notice states 'no-eu-funds'. Actual funding status unc...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Supply of Onasemnogenum abeparvovecum for the hospital's drug program B.102.FM.
  • Detailed scope defined in attachment 2 of the SWZ (not analyzed).
Afficher le résumé complet

This tender is for the supply of the pharmaceutical product Onasemnogenum abeparvovecum for a pediatric hospital in Katowice, Poland. It is a single-lot open procedure with price-only award criteria. No estimated value is provided. The submission deadline is 2026-08-17. Key eligibility includes a valid pharmaceutical wholesale license. The tender is SME-friendly and requires electronic submission.

Risques

No estimated value or detailed scope of work provided; key documents (attachment 2) not analyzed.

Structured data indicates EU funding (isEuFunded: true), but XML notice states 'no-eu-funds'. Actual funding status unc...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must hold a valid concession from the Minister of Health or permit from the Chief Pharmaceutical Inspector for wholesale pharmaceutical distribution or consignment warehouse.
  • No variants allowed.

Administrative

  • Electronic submission via the procurement platform is required.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Price: 100 points (poi-exa) — 100%

Acheteur

Localisation

Katowice, POL

Profil acheteur

Ouvrir le profil

Identifiant

634-23-46-590

Activité

Health

Lots (1)

LOT-0001

Package 1 Onasemnogenum abeparvovecum

Supply of Onasemnogenum abeparvovecum for the hospital's drug program B.102.FM. Detailed description is in attachment 2 of the SWZ. The contract includes an option clause as per SWZ attachments.

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Katowice, Poland

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Expired Aug 17, 2026

Détails de la procédure

Date de publication
09 Jul 2026
Langues
Polish

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
476734-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3